TY  - JOUR

T1  - A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma

JO  - British Journal of Cancer

PY  - 2003/10/06

AU  - Clamp AR

AU  - Blackhall FH

AU  - Vasey P

AU  - Soukop M

AU  - Coleman R

AU  - Halbert G

AU  - Robson L

AU  - Jayson GC

ED  - 

DO  - DOI: 10.1038/sj.bjc.6601285

PB  - Springer Science and Business Media LLC

VL  - 89

IS  - 7

SP  - 1152

EP  - 1154

Y2  - 2025/10/10

ER  -